Is FDG-PET/CT useful for managing malignant pleural mesothelioma?

Journal of Medical Investigation

Volumn 56, Issue 1-2, 2009, Pages 16-20

  Otsuka, Hideki ^a   Terazawa, Kaori ^a   Morita, Naomi ^a   Otomi, Yoichi ^a   Yamashita, Kyo ^a   Nishitani, Hiromu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

FDG PET CT; Malignant pleural mesothelioma

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; COLON POLYP; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINUM LYMPH NODE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATHOLOGICAL ANATOMY; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER;

EID: 63349101354     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.56.16     Document Type: Article

References (13)

1. Robinson BWS, Lake RA: Advances in Malignant Mesothelioma. N Engl J Med 353(15): 1591-1603, 2005
2. WHO: Histological typing of lung and pleural tumors. 3rd Ed, Springer, Berlin, 1999
3. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW: VW. Extrapleural pneumonectomy versus pleurectomy/ decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135(3): 620-6, 2008
4. Flores RM, Krug LM, Rosenzweig KE, Venkatraman E, Vincent A, Heelan R, Akhurst T, Rusch VW: Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1(4): 289-95, 2006
5. Yajnik S, Rosenzweig KE, Mychalczak B, Krug L, Flores R, Hong L, Rusch VW: Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 56(5): 1319-26, 2003
6. Yamamoto M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H: Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Rad 64: 356-366, 2007
7. Roach HD, Davies GJ, Attanoos R, Crane M, Adams H, Phillips S: Asbestos: when the dust settles an imaging review of asbestos-related disease. Radiographics 22: S167-84, 2002
8. Lorenzo B, Feragalli B, Sacco R, Merlino B, Storto ML: Malignant pleural disease. Eur J Radiol 34(2): 98-118, 2000
9. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C: Staging of malignant pleural mesothelioma: comparison CT and MR imaging. Am J Roentgenol 172 (4): 1039-47, 1999
10. Giesel FL, Bischoff H, von Tengg-Kobligk H: Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improvement outcome. Chest 129 (6): 1570-6, 2006
11. Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco J, Larson SM, Rusch VW: Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 132(4): 763-8, 2006
12. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW: Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 126(1): 11-6, 2003
13. Ceresoil GL, Chiti A, Zucali PA: Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F] fluorodeoxyglucose. J Clin Oncol 24: 4587-4593, 2006